Literature DB >> 11786536

A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma.

Michael O Daines1, Gurjit K Khurana Hershey.   

Abstract

Interleukin (IL)-13 mediates its activities via a complex receptor system. Interleukin-13 receptor alpha-1 chain (IL-13Ralpha1) binds IL-13 with low affinity, but does not signal. However, when IL-13Ralpha1 combines with IL-4 receptor alpha (IL-4Ralpha), a signaling high affinity receptor complex for IL-13 is generated. In contrast, IL-13Ralpha2 alone binds IL-13 with high affinity, but does not signal and has been postulated to be a decoy receptor. Herein, we investigated the cellular localization of IL-13Ralpha2 and the regulation of its expression by confocal microscopy and flow cytometry in primary and cultured cells. Our results demonstrate that IL-13Ralpha2 is largely an intracellular molecule, which is rapidly mobilized from intracellular stores following treatment with interferon (IFN)-gamma. Up-regulation of IL-13Ralpha2 surface expression in response to IFN-gamma was rapid, did not require protein synthesis, and resulted in diminished IL-13 signaling. These results provide the first evidence that the IL-13Ralpha2 is predominantly an intracellular molecule and demonstrate a novel mechanism by which IFN-gamma can regulate IL-13 responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786536     DOI: 10.1074/jbc.M108109200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Authors:  Umasundari Sivaprasad; Manoj R Warrier; Aaron M Gibson; Weiguo Chen; Yasuhiro Tabata; Stacey A Bass; Marc E Rothenberg; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

3.  Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.

Authors:  Weiguo Chen; Yasuhiro Tabata; Aaron M Gibson; Michael O Daines; Manoj R Warrier; Marsha Wills-Karp; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

4.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

5.  IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.

Authors:  Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

6.  Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy.

Authors:  Michael O Daines; Weiguo Chen; Yasuhiro Tabata; Bradley A Walker; Aaron M Gibson; J Alexander Masino; Manoj R Warrier; Cori L Daines; Sally E Wenzel; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2006-11-30       Impact factor: 10.793

Review 7.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

8.  Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses.

Authors:  Xiaoyuan Kong; Gary R Hellermann; Weidong Zhang; Prasanna Jena; Mukesh Kumar; Aruna Behera; Sumita Behera; Richard Lockey; Shyam S Mohapatra
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

9.  Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.

Authors:  Yutong Zhao; Donghong He; Jing Zhao; Lixin Wang; Alan R Leff; Ernst Wm Spannhake; Steve Georas; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

Review 10.  Interleukin-13 in asthma pathogenesis.

Authors:  Marsha Wills-Karp
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.